Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. (BPL) is a leading biopharmaceutical company headquartered in the United Kingdom. Established in 1983, BPL has made significant strides in the development and manufacture of high-quality plasma-derived therapies, primarily serving patients with rare and chronic conditions. With operational facilities in the UK and a growing presence in international markets, BPL is committed to advancing healthcare through innovative solutions. The company’s core products include immunoglobulins, clotting factors, and albumin, all distinguished by their rigorous quality standards and commitment to patient safety. BPL's dedication to research and development has positioned it as a trusted partner in the biopharmaceutical industry, recognised for its contributions to patient care and its robust pipeline of therapies. With a focus on excellence and innovation, Bio Products Laboratory Ltd. continues to enhance its market position and deliver impactful healthcare solutions globally.
DitchCarbon Score
How does Bio Products Laboratory Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bio Products Laboratory Ltd.'s score of 26 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bio Products Laboratory Ltd.'s reported carbon emissions
In 2019, Bio Products Laboratory Ltd. reported total carbon emissions of approximately 15,132,780 kg CO2e for Scope 1 and about 32,896,560 kg CO2e for Scope 2, resulting in a combined total of approximately 48,029,340 kg CO2e. The company has set an ambitious target to reduce its Scope 1 and 2 emissions by 46.2% from this 2019 baseline by the year 2030. This commitment reflects a proactive approach to climate action, aiming for significant reductions in their carbon footprint. As a current subsidiary, Bio Products Laboratory Ltd. inherits its emissions data and reduction initiatives from its corporate family structure. The reduction targets are part of a broader strategy to enhance sustainability and align with industry standards for climate commitments. The company has not disclosed any Scope 3 emissions data, indicating a focus on direct and indirect emissions from its operations and energy use. Overall, Bio Products Laboratory Ltd. is taking substantial steps towards mitigating its environmental impact, with clear targets set for the near term.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | |
|---|---|---|
| Scope 1 | 13,450,950 | 00,000,000 |
| Scope 2 | 29,340,110 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bio Products Laboratory Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
